Codes / ICD10CM / T38.895S

T38.895S Adverse effect of other hormones and synthetic substitutes, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of other hormones and synthetic substitutes, sequela

Summary

This condition represents a residual effect (sequela) resulting from an adverse reaction to hormones or their synthetic substitutes that are not classified elsewhere. It applies when the adverse effect has persisted beyond the acute phase of the initial event, leading to chronic or long-term consequences. The code is used when the sequela is directly attributable to the prior adverse effect of these agents.

Causes

The causes stem from prior exposure to hormones, their synthetic analogues, or antagonists, which may have occurred during therapeutic use, accidental ingestion, or incorrect dosing. The sequela arises as a complication of the initial adverse effect, reflecting lasting physiological or structural changes resulting from the original reaction.

Risk Factors

  • History of adverse reactions to hormonal agents
  • Prolonged or high-dose use of hormone therapies
  • Underlying organ dysfunction (e.g., renal or hepatic impairment)
  • Individual sensitivity to hormonal substances
  • Incomplete recovery from the initial adverse event

Symptoms

Symptoms depend on the specific hormone or agent involved and the nature of the sequela. They may include persistent metabolic disturbances, endocrine imbalances, organ dysfunction, or structural damage. Manifestations could range from chronic pain to irreversible organ impairment, depending on the severity of the initial adverse effect.

Diagnosis

Diagnosis requires correlation of the current condition with a documented prior adverse effect of hormones or synthetic substitutes. Clinical evaluation, patient history, and evidence of residual damage (e.g., imaging or lab results) are necessary to confirm the sequela. The timeline between the initial event and the sequela must be established.

Treatment Options

Treatment focuses on managing the residual effects and preventing further complications. This may involve symptom relief, rehabilitation, or long-term monitoring. Interventions are tailored to the specific sequela, such as hormone replacement, organ support, or lifestyle modifications to address ongoing dysfunction.

Prognosis and Follow-Up

Prognosis varies based on the severity and type of sequela. Some effects may be manageable with ongoing care, while others could be permanent. Regular follow-up is essential to monitor for progression, adjust treatments, and address any new symptoms. Long-term management may be required to optimize quality of life.

Complications

Complications can include chronic organ damage, persistent endocrine disorders, or reduced functional capacity. In severe cases, irreversible harm may occur, necessitating ongoing medical support. Early intervention and adherence to follow-up care can mitigate risks.

Lifestyle & Prevention

Lifestyle adjustments may help manage symptoms, such as dietary changes or exercise. Prevention focuses on avoiding re-exposure to the causative agent and adhering to prescribed therapies. Patients should be educated on recognizing early signs of recurrence and maintaining open communication with healthcare providers.

When to Seek Professional Help

Seek medical attention if new or worsening symptoms arise, indicating potential progression of the sequela. Prompt evaluation is necessary for unexplained pain, organ dysfunction, or signs of acute deterioration. Routine follow-up appointments should be maintained as recommended.

Tips for Medical Coders

Document the relationship between the sequela and the prior adverse effect of hormones or synthetic substitutes. Ensure the initial event is clearly linked to the current condition, and specify the nature of the sequela (e.g., organ damage, metabolic disorder). Use this code only when the sequela is a direct result of the adverse effect and not assigned to a more specific code.

Book a walkthrough

T38.895S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.